Table 3.

Comparison of the low and high CAA-SVD score groups in the mixed CMBs group with a high HA-SVD score

	low CAA-SVD score (n = 11)	high CAA-SVD score (n = 32)	p
Age, y, mean±SD	81.2±6.1	74.8±8.4	0.025∗
Male, n (%)	4 (36.4)	14 (43.8)	0.736
MMSE, median (IQR)	20 (18–23)	24 (19–26)	0.356
Hypertension, n (%)	5 (45.5)	14 (43.8)	1
Diabetes mellitus, n (%)	2 (18.2)	5 (15.6)	1
Dyslipidemia, n (%)	7 (38.9)	15 (42.9)	1
Smoking, n (%)	3 (27.3)	7 (21.9)	0.698
HA-SVD-Score, median (IQR)
Lacune	0 (0–1)	1 (1–1)	0.483
CMBs	1 (1–1)	1 (1–1)	1
BG-PVS	1 (1–1)	1 (1–1)	0.880
WMH	1 (0–1)	1 (1–1)	0.386
Total	3 (3–4)	4 (3–4)	0.154
CAA-SVD-Score, median (IQR)
Lobar CMBs	0 (0–1)	2 (2–2)	<0.001∗
cSS	0 (0–0)	0 (0–0)	0.555
CSO-PVS	0 (0–1)	1 (0–1)	0.117
WMH	1 (0–1)	1 (1–1)	0.386
Total	2 (1–2)	4 (3–4)	<0.001∗

BG, basal ganglia; CAA, cerebral amyloid angiopathy; CMB, cerebral microbleed; CSO, centrum semiovale; cSS, cortical superficial siderosis; HA, hypertensive arteriopathy; IQR, interquartile range; MMSE, Mini-Mental State Examination; PVS, perivascular space; SD, standard deviation; SVD, small vessel disease; WMH, white matter hyperintensity.

^∗p < 0.05 for low CAA-SVD score versus high CAA-SVD score.